Nipra - Significant Presence in Pharmaceutical Closure Segment

Pharmaceutical and biotechnology companies are leading end-users of aluminum closures. The increasing demand for safe and easy packaging has encouraged innovations in the field of pharmaceutical caps and the closures market. With a focus on effective packaging to minimize the risk of accidents and spoilage of pharmaceutical products, the demand in the market is expected to increase.

The COVID-19 pandemic has changed priorities in the national healthcare process and spending. However, it is considered to have a short-term negative impact on the pharmaceutical caps and closures market. Future Market Insights expects the global pharmaceuticals aluminum closures market to rise at 5.7 % CAGR between 2021 and 2031.

The Nipra group has a significant presence in the pharmaceutical closure segment in India and abroad. Pharmaceutical closures manufactured by Nipra have options in decoration that can resist retort (autoclave). These closures are produced on high-speed automatic lines which ensure fast service to clients. The functional options include internal liners in either EPE (Extruded polyethylene), Cork-PVC or SBR (rubber liners).

Since the past few years, Nipra has expanded immensely. These vast expansions have led to some great achievements by the company. Nipra is also appreciated as the largest aluminum closure stock converter and metal printer in the Indian sub-continent. As far as the domestic market is concerned, Nipra provides packaging solutions to various industry sectors. Nipra products provide optimum value for money for our customers.

To know more about this aluminum closure manufacturer, visit


Popular posts from this blog

Aluminum in Competition With Other Materials

For Nipra Group, Spirit Closures Represent the Largest Business Division